Timing the initiation of multiple myeloma

Journal: Nature Communications

Published: 2020-04-21

DOI: 10.1038/s41467-020-15740-9

Affiliations: 22

Authors: 26

Go to article
Institutions Share
Wellcome Sanger Institute, United Kingdom (UK) 0.25
Memorial Sloan Kettering Cancer Center (MSKCC), United States of America (USA) 0.15
IRCCS Istituto Nazionale dei Tumori (INT), Milan, Italy 0.12
University of Milan (UNIMI), Italy 0.06
Dana-Farber/Brigham and Women’s Cancer Center (DF/BWCC), United States of America (USA) 0.06
University of California, San Francisco (UCSF), United States of America (USA) 0.04
Centre de Recherche en Cancérologie de Toulouse (CRCT), France 0.04
Ulm University Medical Center, Germany 0.04
August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Spain 0.03
Biomedical Research Networking Centers (CIBER), Spain 0.03
Hospital Clinic of Barcelona, Spain 0.03
University of Oviedo (UniOvi), Spain 0.03
SIRIC ILIAD, France 0.02
Computational Oncology Service, MSKCC, United States of America (USA) 0.02
Center for Research in Cancerology and Immunology Nantes-Angers (CRCINA), France 0.02
University of Turin (UNITO), Italy 0.02
VA Boston Healthcare System, United States of America (USA) 0.02
UC San Diego Health Sciences, United States of America (USA) 0.01
UC San Diego Health System, United States of America (USA) 0.01
University of California, San Diego (UC San Diego), United States of America (USA) 0.01

Return

Except where otherwise noted © 2021 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER